Table: q1_q4_2023_prescription_drug_wac_increases , manufacturer_name like F*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id manufacturer_name date_reported ndc_number drug_product_description drug_category drug_category_source wac_effective_date wac_increase_amount wac_after_increase patent_expiration_date drug_source_type unit_sales_volume_in_us unit_sales_volume_non_public_indicator cost_increase_factors cost_increase_factors_non_public_indicator change_improvement_description change_improvement_non_public_indicator acquisition_date company_acquired_from acquisition_price acquisition_price_non_public_indicator acquisition_price_comment wac_at_acquisition wac_year_prior_to_acquisition year_drug_introduced_to_market wac_at_intro_to_market supporting_documents general_comments
Rx0000501 FH2 Pharma LLC 03/31/2023 72887064812 OXYCODONE & PARACETAMOL ORAL SOLUTION 1 BOTTLE 120 ML 240 MG/7200 MG Generic FDA 02/01/2023 925.00 2625.00 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323036061 Calcium Gluconate Intravenous Solution 10 % 100 ML, Vial Qty 20 Brand FDA 02/02/2023 93.60 1079.20 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323036059 Calcium Gluconate Intravenous Solution 10 % 50 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 58.50 674.50 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323038510 cefoTEtan Disodium Injection Solution Reconstituted 1 GM 1 Each, Unit-Dose, Vial Qty 10 Generic FDA 02/02/2023 31.60 242.20 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323038620 cefoTEtan Disodium Injection Solution Reconstituted 2 GM 1 Each, Unit-Dose, Vial Qty 10 Generic FDA 02/02/2023 63.20 484.40 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323001115 Chloramphenicol Sodium Succinate For IV Inj 1 GM, 1 Each, Unit-Dose, Vial Qty 10 Generic FDA 02/02/2023 97.30 486.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 12/31/2023 63323012710 Dacarbazine Intravenous Solution Reconstituted 100 MG 10 vials per package Generic FDA 10/31/2023 15.20 123.90 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323050601 Dexamethasone Sod Phosphate PF Injection Solution 10 MG/ML 1 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 16.25 187.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323051610 Dexamethasone Sodium Phosphate Injection Solution 100 MG/10ML 10 ML, Vial Qty 10 Generic FDA 02/02/2023 13.40 154.90 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323001002 Gentamicin Sulfate Inj 40 MG/ML, 2 ML, Vial Qty 25 Generic FDA 02/02/2023 13.25 101.75 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323001020 Gentamicin Sulfate Inj 40 MG/ML, 20 ML, Vial Qty 25 Generic FDA 02/02/2023 95.25 730.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323017302 Gentamicin Sulfate Injection Solution 10 MG/ML 2 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 17.75 135.25 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 09/30/2023 63323017394 Gentamicin Sulfate Injection Solution 10 MG/ML Package size: 2ML Vial Package Quantity: 25 Vials Generic FDA 08/01/2023 5.50 55.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 06/30/2023 63323059303 Glucagon HCl (Diagnostic) Injection Solution Reconstituted 1 MG Package Size 1 Package Quantity 1 Brand FDA 06/01/2023 51.15 221.65 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 06/30/2023 63323059613 Glucagon HCl (Diagnostic) Injection Solution Reconstituted 1 MG Package Size 1 Package Quantity 10 Brand FDA 06/01/2023 511.50 2216.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323085225 HYDROmorphone HCl PF Injection Solution 1 MG/ML 1 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 18.00 108.00 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323085150 HYDROmorphone HCl PF Injection Solution 10 MG/ML 50 ML, Unit-Dose, Vial Brand FDA 02/02/2023 28.34 170.04 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323085325 HYDROmorphone HCl PF Injection Solution 2 MG/ML 1 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 18.00 108.00 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323085410 HYDROmorphone HCl PF Injection Solution 4 MG/ML 1 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 18.75 112.00 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323034925 Imipenem-Cilastatin Intravenous Solution Reconstituted 250 MG 1 Each, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 32.50 374.75 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323032225 Imipenem-Cilastatin Intravenous Solution Reconstituted 500 MG Each, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 65.00 749.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323020805 Lidocaine HCl (Cardiac) IV PF Soln 100 MG/5ML (2%), 5 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 11.25 86.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323006411 Magnesium Sulfate Inj 50%, 10 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 7.00 54.25 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323006403 Magnesium Sulfate Inj 50%, 2 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 6.50 49.75 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323064220 Magnesium Sulfate Injection Solution 50 % 20 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 29.50 226.25 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323064250 Magnesium Sulfate Injection Solution 50 % 50 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 76.00 582.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323002425 Mannitol Intravenous Solution 25 % 50 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 11.50 133.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323025410 Muri-Lube Oil 10 ML, Unit-Dose, Vial Qty 25 Brand Medispan 02/02/2023 57.25 438.25 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323025402 Muri-Lube Oil 2 ML, Unit-Dose, Vial Qty 25 Brand Medispan 02/02/2023 49.50 379.25 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323020500 Omegaven Intravenous Emulsion 10 GM/100ML 100 ML, Unit-Dose, Vial Qty 10 Brand FDA 02/02/2023 47.30 835.70 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323020550 Omegaven Intravenous Emulsion 5 GM/50ML 50 ML, Unit-Dose, Vial Qty 10 Brand FDA 02/02/2023 33.10 585.00 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323001230 Oxytocin Inj 10 Unit/ML, 30 ML, Vial Qty 10 Brand FDA 02/02/2023 41.10 473.60 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 65219005229 Potassium Phosphates Intravenous Solution 15 MMOLE/5ML 22 mEq/5ML (K), 5 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 52.00 599.50 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 65219005629 Potassium Phosphates Intravenous Solution 150 MMOLE/50ML 220 mEq/50ML (K), 50 ML, Vial Qty 25 Brand FDA 02/02/2023 257.50 2967.75 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 65219005429 Potassium Phosphates Intravenous Solution 45 MMOLE/15ML 66 mEq/15ML (K), 15 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 104.00 1199.00 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323022930 Protamine Sulfate Inj 10 MG/ML, 25 ML, Unit-Dose, Vial Generic FDA 02/02/2023 6.05 46.41 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323022905 Protamine Sulfate Intravenous Solution 10 MG/ML 5 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 50.50 387.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323018001 Pyridoxine HCl Injection Solution 100 MG/ML 1 ML, Vial Qty 25 Generic FDA 02/02/2023 62.25 476.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323046157 Sensorcaine/EPINEPHrine Injection Solution 0.25% -1:200000 50 ML, Vial Qty 25 Generic FDA 02/02/2023 22.00 390.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323046357 Sensorcaine/EPINEPHrine Injection Solution 0.5% -1:200000 50 ML, Vial Qty 25 Generic FDA 02/02/2023 23.75 418.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323046817 Sensorcaine-MPF/EPINEPHrine Injection Solution 0.25% -1:200000 10 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 8.75 154.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323046837 Sensorcaine-MPF/EPINEPHrine Injection Solution 0.25% -1:200000 30 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 13.75 243.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323046217 Sensorcaine-MPF/EPINEPHrine Injection Solution 0.5% -1:200000 10 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 9.00 158.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323046237 Sensorcaine-MPF/EPINEPHrine Injection Solution 0.5% -1:200000 30 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 14.75 262.25 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323046037 Sensorcaine-MPF/EPINEPHrine Injection Solution 0.75-1:200000 % 30 ML, Unit-Dose, Vial Qty 25 Brand FDA 02/02/2023 16.75 294.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323009040 Sodium Chloride Injection Solution 2.5 MEQ/ML (14.6%), 40 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 25.00 191.00 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323009330 Sodium Chloride Intravenous Solution 4 MEQ/ML (23.4%), 30 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 21.75 167.75 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323018510 Sterile Water for Injection Injection Solution 10 ML, Unit-Dose, Vial Qty 25 Generic FDA 02/02/2023 14.25 109.75 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323030502 Tobramycin Sulfate Injection Solution 10 MG/ML (Base Equivalent), 2 ML, Vial Qty 25 Generic FDA 02/02/2023 21.50 153.50 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 12/31/2023 63323027810 vinBLAStine Sulfate Intravenous Solution 1 MG/ML 1 vial per package Generic FDA 10/31/2023 6.60 53.76 None Non-innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323048217 Xylocaine/EPINEPHrine Injection Solution 1 %-1:100000 10 ML, Vial Qty 25 Brand FDA 02/02/2023 5.00 86.75 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000129 Fresenius Kabi USA LLC 03/31/2023 63323048257 Xylocaine/EPINEPHrine Injection Solution 1 %-1:100000 50 ML, Vial Qty 25 Brand FDA 02/02/2023 14.25 250.50 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None